- Bio X Cell will open a new distribution center in Beijing, China, in March 2025.
- The expansion aims to improve service for researchers in China by increasing inventory availability and reducing order fulfillment times.

Bio X Cell, a provider of functional antibodies for translational research, is expanding its international footprint with a new distribution center in Beijing, China, set to open in March 2025. This marks a strategic move to enhance service for researchers and institutions across the region by increasing local inventory and expediting deliveries.
The Beijing facility will complement Bio X Cell’s flagship distribution center in Germany and existing partnerships in Singapore and Korea. With its headquarters and manufacturing operations in New Hampshire, the company continues to strengthen its global supply chain to better support the growing demand for its products.
By establishing a stronger presence in the Asia-Pacific (APAC) region, Bio X Cell aims to meet the needs of researchers in one of the fastest-growing biomedical research markets. The company expects the new hub to reduce lead times and improve access to its functional antibodies.
“This new distribution center underscores our commitment to delivering high-quality functional antibodies to researchers worldwide with greater efficiency and reliability,” said Chris Conway, CEO of Bio X Cell. “With increased inventory on hand in Beijing, we can reduce lead times and provide faster access to the essential reagents that fuel groundbreaking scientific discoveries.”